/PRNewswire/ The "Active Pharmaceutical Ingredients (API) Global Market - Forecast To 2029" & "Pharmaceutical Excipients Global Market - Forecast To 2029".
Molnupiravir, Merck's new COVID-19 pill, developed with $35M in taxpayer NIH/NIAID funding to Emory University, is being sold to the Biden admin at 3,500% markup.
Foreign investors should note that PLI schemes are fast becoming the preferred vehicle for India's incentives to boost local manufacturing capacity creation.